LSI TRANACIX Day Cream SPF 50+ – Anti-pigmentation cream (1 x 30 g)

LSI TRANACIX Day Cream SPF 50+ – Anti-pigmentation cream (1 x 30 g)

39,00 €

LSI TRANACIX Day Cream SPF 50+ is a day cream containing 3% tranexamic acid, designed for the care of skin with hyperpigmentation, helping to even out skin tone while providing high sun protection.

Purchases are available only to verified professional customers. Register first!

SKU: 100056|UNIW Categories: , Brand:

Free

Shipping in Europe
for orders over 1000 €

100%

Guaranteed
Satisfaction

Safe

Stripe
Payments

LSI TRANACIX Day Cream SPF 50+ is a specialized day cream developed for the care of skin prone to hyperpigmentation, uneven skin tone, and visible signs of photoaging. The product combines the brightening properties of tranexamic acid with high-level SPF 50+ sun protection, helping to reduce existing pigmentary imperfections while preventing the formation of new dark spots.

The formula contains 3% tranexamic acid, an ingredient used in the treatment of skin with pigmentation disorders. It works by inhibiting processes that lead to excessive melanin production, thereby helping to diminish the appearance of hyperpigmentation, even out skin tone, and improve the overall complexion.

The inclusion of high-level SPF 50+ sun protection helps shield the skin from the harmful effects of UVB radiation, which contributes to the development of dark spots, photoaging, and skin damage. Regular use of the cream helps maintain a more uniform skin tone and reduces the risk of existing pigmentary issues worsening due to sun exposure.

This product is an ideal component of a daily skincare routine for those seeking to brighten their complexion, protect their skin, and achieve a more even skin tone. It can be used as a complementary treatment alongside regimens focused on reducing sun-induced or post-inflammatory hyperpigmentation.

Indications for use:

  • Sun-induced and post-inflammatory hyperpigmentation.
  • Uneven skin tone.
  • Skin prone to excessive pigmentation. Visible pigment spots.
  • Melasma – as part of a supportive skincare regimen.
  • Signs of photoaging.
  • Skin requiring daily sun protection.
  • Prevention of the development or worsening of hyperpigmentation.

Benefits of use:

  • Reduced visibility of hyperpigmentation and pigment spots.
  • Brightened and more even skin tone.
  • Prevention of new hyperpigmentation caused by UV exposure.
  • High sun protection (SPF 50+).
  • Support in the prevention of photoaging.
  • Improved skin uniformity and radiance.
  • Enhanced overall appearance and condition of the skin.

Active ingredients:

  • Tranexamic Acid 3% – an ingredient with brightening and depigmenting properties that helps reduce hyperpigmentation, even out skin tone, and inhibit processes that lead to excessive pigmentation.
  • SPF 50+ sun filters – provide very high protection against UVB radiation, helping to reduce the risk of sunburn, photoaging, and the development of sun-induced hyperpigmentation.

Directions for use:

  • Cleanse and thoroughly dry the skin on your face.
  • Apply an appropriate amount of the cream to the face, neck, and décolletage.
  • Spread the product gently and evenly.
  • Use every morning as the final step in your skincare routine, before applying makeup.
  • Reapply approximately every 2 hours when exposed to the sun, as well as after swimming, heavy sweating, or wiping the skin.

Package contents:

  • 1 × 30 g.

For professional use only.
By purchasing this product, you declare that you are a physician or a cosmetologist trained in the field of aesthetic medicine.

Reviews

There are no reviews yet.

Be the first to review “LSI TRANACIX Day Cream SPF 50+ – Anti-pigmentation cream (1 x 30 g)”
Dear User Please be advised that the shopping platform fillora.store and all information contained therein is intended for professionals related to aesthetic medicine.
By proceeding further you declare that: You are a professional related to aesthetic medicine, you are qualified in this field or you have a business related to the medical industry.